Atlas FDA

PIPELINE EMBOLIZATION DEVICE

FDA premarket approval P100018 · decided 2011-04-06

Approval details

PMA number
P100018
Trade name
PIPELINE EMBOLIZATION DEVICE
Generic name
Intracranial aneurysm flow diverter
Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Date received
2010-05-18
Decision date
2011-04-06
Days to decision
323 days
Decision code
APPR
Product code
OUT
Advisory committee
Neurology
Expedited review
Yes
Location
Irvine, CA
Statement
APPROVAL FOR THE PIPELINE EMBOLIZATION DEVICE. THIS DEVICE IS INDICATED FOR THE ENDOVASCULAR TREATMENT OF ADULTS (AGE 22 AND ABOVE) WITH LARGE OR GIANT WIDE-NECKED INTRACRANIAL ANEURYSMS IN THE INTERNAL CAROTID ARTERY FROM THE PETROUS TO THE SUPERIOR HYPOPHYSEAL SEGMENTS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Rist 079 Radial Access Guide Catheter; Rist 071 Radial Access Guide Catheter; Rist Radial Access Selective Catheter (K241388)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2025-01-02
Riptide™ Aspiration Pump; Riptide™ Collection Canister with Intermediate Tubing (K243418)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-12-02
Riptide Aspiration System (K243080)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2024-10-29
Rist 071 Radial Access Guide Catheter (K211990)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-07-27
Axium Detachable Coil; Axium Prime Detachable Coil (K203432)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-07-07
Solitaire X Revascularization Device (K203358)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-03-01
Concerto Versa, Detachable Coil (K202850)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2021-02-09
Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device) (K193576)Micro Therapeutics, Inc. d/b/a ev3 Neurovascular2020-11-20